Hyperpolarizing effects of dopamine on chemoreceptor nerve endings from cat and rabbit carotid bodies in vitro.
1. The effects of dopamine on DC potential changes recorded from the carotid sinus nerve were studied in vitro using carotid bodies and associated sinus nerves removed from anaesthetized cats and rabbits.2. The carotid body was placed in one compartment of a superfusion chamber and was superfused with buffered salt solution. The carotid sinus nerve was led into an adjoining compartment, containing lightweight mineral oil, for recording DC potential changes with chlorided silver electrodes.3. Dopamine injected into the superfusing solution in amounts of 50-250 mug caused hyperpolarization of the DC potential. This effect occurred repeatedly in each preparation, the maximum number of tests in any one preparation being twenty-seven.4. In the same preparations, acetylcholine (50-100 mug) and NaCN (10-20 mug) caused depolarizations of the DC potential, effects that have been described by others.5. The hyperpolarizing effects of dopamine were reduced or abolished by the alpha-adrenergic antagonists, dihydroergotamine (10-100 mug/ml.) and phenoxybenzamine (5 mug/ml.) and the dopamine antagonist droperidol (10-25 mug/ml.).6. The results indicate that the inhibitory effects of dopamine on the frequency of carotid body chemosensory discharges in cats and rabbits are due to hyperpolarization of chemoreceptor afferent nerve endings and not necessarily to local vascular effects in the carotid body.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D002344:Carotid Body / Q000187:drug effects*; D002346:Carotid Sinus / Q000294:innervation; D002415:Cats; D004298:Dopamine / Q000494:pharmacology*; D018492:Dopamine Antagonists; D066298:In Vitro Techniques; D008564:Membrane Potentials / Q000187:drug effects*; D051381:Rats
D000317:Adrenergic alpha-Antagonists; D018492:Dopamine Antagonists; D004298:Dopamine